Novo Nordisk said it expects the European Medicines Agency to implement the EU label update on Wegovy to reflect reduced heart failure symptoms and improved physical function shortly. The company also ...

The European Medicines Agency backed the use of Novo Nordisk's NOVOb.CO popular drug Wegovy to help ease heart failure in ...

Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a ...

Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...

With its line-up of sweet snacks, Hershey isn’t known as a purveyor of diet foods. However, the company’s newest products are ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up ...

This included things like injection site injury (ROR 52.78, 95% CI 45.75-60.89 ... It had better overall gastrointestinal tolerability than semaglutide (Ozempic, Wegovy), but worse than lixisenatide ...

An experimental weight-loss pill helped people drop 13% of their body weight in a three-month period. The results from early ...

The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that delivered weight loss success by taking a daily pill.

There are seven FDA-approved weight loss medications currently available. These medications are safe and effective and have minimal side effects.

The biotech continued to get attention from both pundits and investors, thanks largely to its investigational obesity drug.